Consolidated Statement Of Income

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7728785

Concept 2017-04-01 to
2017-12-31
2017-04-01 to
2017-12-31
2017-04-01 to
2017-12-31
2017-04-01 to
2017-12-31
2017-04-01 to
2017-12-31
2016-04-01 to
2016-12-31
2016-04-01 to
2016-12-31
2016-04-01 to
2016-12-31
2016-04-01 to
2016-12-31
2016-04-01 to
2016-12-31
Consolidated statement of income
Statement of income
Net sales
76,891,000,000 JPY
JPY
75,099,000,000 JPY
76,891,000,000 JPY
1,792,000,000 JPY
77,177,000,000 JPY
1,787,000,000 JPY
78,965,000,000 JPY
78,965,000,000 JPY
JPY
Cost of sales
32,484,000,000 JPY
33,911,000,000 JPY
Operating expenses
Selling, general and administrative expenses
20,700,000,000 JPY
20,100,000,000 JPY
Other
7,651,000,000 JPY
7,723,000,000 JPY
Operating expenses
Ordinary profit (loss)
24,062,000,000 JPY
25,232,000,000 JPY
Operating profit (loss)
23,706,000,000 JPY
JPY
22,469,000,000 JPY
23,706,000,000 JPY
1,237,000,000 JPY
23,732,000,000 JPY
1,221,000,000 JPY
24,953,000,000 JPY
24,953,000,000 JPY
JPY
Net sales
Gross profit (loss)
44,406,000,000 JPY
45,053,000,000 JPY
Operating expenses
Research and development expenses
5,778,000,000 JPY
4,985,000,000 JPY
Cost of sales
Non-operating income
378,000,000 JPY
318,000,000 JPY
Dividend income
301,000,000 JPY
275,000,000 JPY
Interest income
3,000,000 JPY
4,000,000 JPY
Non-operating income
Other
73,000,000 JPY
39,000,000 JPY
Extraordinary income
JPY
252,000,000 JPY
Selling, general and administrative expenses
Salaries
5,379,000,000 JPY
5,472,000,000 JPY
Non-operating expenses
Interest expenses
12,000,000 JPY
16,000,000 JPY
Other
10,000,000 JPY
22,000,000 JPY
Non-operating expenses
22,000,000 JPY
39,000,000 JPY
Extraordinary losses
51,000,000 JPY
82,000,000 JPY
Other
11,000,000 JPY
JPY
Profit (loss) before income taxes
24,011,000,000 JPY
25,402,000,000 JPY
Gross profit
Extraordinary income
Gain on sale of investment securities
JPY
252,000,000 JPY
Extraordinary losses
Loss on retirement of non-current assets
39,000,000 JPY
65,000,000 JPY
Income taxes
7,152,000,000 JPY
7,419,000,000 JPY
Profit (loss)
16,859,000,000 JPY
17,983,000,000 JPY
Profit (loss) attributable to owners of parent
16,859,000,000 JPY
17,983,000,000 JPY
Profit attributable to
Other comprehensive income
Valuation difference on available-for-sale securities
1,288,000,000 JPY
469,000,000 JPY
Remeasurements of defined benefit plans, net of tax
333,000,000 JPY
329,000,000 JPY
Other comprehensive income
1,621,000,000 JPY
798,000,000 JPY
Comprehensive income
18,481,000,000 JPY
18,782,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
18,481,000,000 JPY
18,782,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.